Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iSCLife77
- Development stage
- Preclinical
- Lead developer
- Sclnow Biotechnology
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies, Stem Cell Therapies → Cell Therapies
- Administration
- Ophthalmic
01
Overview
iSCLife77 (also known as iSCLife®77 or SCLnow® Tissue Engineering) is a tissue-engineered stem cell membrane product developed by Sclnow Biotechnology for corneal transplantation. The product is derived from umbilical cord pluripotent stem cells and processed into a transparent, tenacious membrane using proprietary technologies. It is designed to address the scarcity of donor corneal tissue by providing a regenerative scaffold that repairs or replaces damaged corneal tissue. iSCLife77 exhibits natural low immunogenicity and works through regenerative mechanisms to restore corneal function, leveraging the high transparency and tenacity of the stem cell-derived membrane for ocular tissue engineering applications.
- Brand names
- iSCLife®77SCLnow® Tissue Engineering
- Other names
- Stem Cell MembraneiSCLife 77iSCLife77iSCLife-77
Beyond the preview
Go deeper on iSCLife77.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iSCLife77.